These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25029850)

  • 1. [Risks and benefits: new concepts of treatment of late-onset hypogonadism].
    Shang XJ; Huang YF
    Zhonghua Nan Ke Xue; 2014 Jun; 20(6):483-9. PubMed ID: 25029850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological management of late-onset hypogonadism.
    Rastrelli G; Maggi M; Corona G
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):439-458. PubMed ID: 29505313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
    Amano T
    Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late-onset hypogonadism in men: uncertain disease entity and reservations regarding treatment with testosterone].
    Nieuwenhuijzen Kruseman AC
    Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1925-8. PubMed ID: 16999276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
    Turchi P; Simi S; Pescatori ES
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of androgen in the elderly. What is LOH syndrome?].
    Hisasue S; Horie S
    Clin Calcium; 2013 Aug; 23(8):1101-7. PubMed ID: 23892209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone for 'late-onset hypogonadism' in men?
    Drug Ther Bull; 2010 Jun; 48(6):69-72. PubMed ID: 20530029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Testosterone undecanoate for late -onset hypogonadism: an update].
    Fan XB; Huang YF
    Zhonghua Nan Ke Xue; 2010 Jan; 16(1):68-71. PubMed ID: 20180410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of salivary testosterone and dehydroepiandrosterone using LC-MS/MS: Method development and evaluation of applicability for diagnosis and medication for late-onset hypogonadism.
    Shibayama Y; Higashi T; Shimada K; Odani A; Mizokami A; Konaka H; Koh E; Namiki M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(25):2615-23. PubMed ID: 19010090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.
    Tsujimura A; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Takao T; Nonomura N; Okuyama A
    Aging Male; 2011 Mar; 14(1):76-81. PubMed ID: 20712429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Therapy for Male Hypogonadism.
    Carrasquillo R; Chu K; Ramasamy R
    Curr Urol Rep; 2018 Jun; 19(8):63. PubMed ID: 29886559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone and Men's Health. Late-onset hypogonadism in males and male menopause (andropause)].
    Komiya A; Watanabe A; Fuse H
    Clin Calcium; 2010 Feb; 20(2):234-44. PubMed ID: 20118516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estrogens and male sexuality: efficiency of antiestrogens in case of hypothalamic hypogonadism and late onset hypogonadism].
    Martin-Du Pan RC
    Rev Med Suisse; 2011 Mar; 7(287):644-7. PubMed ID: 21542378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment and management of male androgen disorders: an update.
    Chan I; Fui MN; Zajac JD; Grossmann M
    Aust Fam Physician; 2014 May; 43(5):277-82. PubMed ID: 24791767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging medication for the treatment of male hypogonadism.
    Corona G; Rastrelli G; Vignozzi L; Maggi M
    Expert Opin Emerg Drugs; 2012 Jun; 17(2):239-59. PubMed ID: 22612692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone therapy in men.
    Theodoraki A; Bouloux PM
    Menopause Int; 2009 Jun; 15(2):87-92. PubMed ID: 19465676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
    La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
    Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
    Mäkinen JI; Huhtaniemi I
    Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.